Jiangsu Hengrui Medicine
600276.SS
#508
Rank
โ‚น3.398 T
Marketcap
โ‚น532.69
Share price
-0.27%
Change (1 day)
4.51%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total assets

Total assets on the balance sheet as of June 2024 : โ‚น556.32 B

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total assets are โ‚น556.32 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Jiangsu Hengrui Medicine - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2022-12-31โ‚น508.18 B10.66%
2021-12-31โ‚น459.22 B18.12%
2020-12-31โ‚น388.77 B38.46%
2019-12-31โ‚น280.78 B23.31%
2018-12-31โ‚น227.69 B28.61%
2017-12-31โ‚น177.04 B26.25%
2016-12-31โ‚น140.23 B18.98%
2015-12-31โ‚น117.86 B26.91%
2014-12-31โ‚น92.87 B25.96%
2013-12-31โ‚น73.73 B42.47%
2012-12-31โ‚น51.75 B27.62%
2011-12-31โ‚น40.55 B53.54%
2010-12-31โ‚น26.41 B29.15%
2009-12-31โ‚น20.45 B24.33%
2008-12-31โ‚น16.44 B47.86%
2007-12-31โ‚น11.12 B33.52%
2006-12-31โ‚น8.33 B16.23%
2005-12-31โ‚น7.16 B20.01%
2004-12-31โ‚น5.97 B-25.38%
2003-12-31โ‚น8.00 B14.7%
2002-12-31โ‚น6.97 B6.98%
2001-12-31โ‚น6.52 B